Home › Funds › Bleichroeder LP › IRD

Bleichroeder LP position in IRD

OPUS GENETICS INC · Health Care

Bleichroeder LP reported holding 736,842 shares of IRD (OPUS GENETICS INC) in its Q2 2026 13F filing — a position valued at US$3.0M, representing 0.54% of its reported portfolio and ranking #27 among its reported holdings. Bleichroeder LP has disclosed IRD holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)736.84K sh
Reported value held$3.03M
Portfolio Weight0.54%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bleichroeder LP's IRD position evolved

Bleichroeder LP first disclosed a stake in IRD in Q1 2025 at 736,842 shares (US$723K). The position peaked in Q1 2026 at 736,842 shares, worth US$3.4M. Across 6 filings, Bleichroeder LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 736,842 shares valued at US$3.0M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 736.84K $723.43K New
Q2 2025 736.84K $694.18K Hold
Q3 2025 736.84K $1.22M Hold
Q4 2025 736.84K $1.48M Hold
Q1 2026 736.84K $3.35M Hold
Q2 2026 736.84K $3.03M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IRD and 13F data

IRD (OPUS GENETICS INC) is a Health Care company. 68 other funds we track also report a position in IRD — the largest reported positions include Caligan Partners LP (US$25.0M), BIOS Capital Management, LP (US$15.1M), Boxer Capital Management, LLC (US$11.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IRD

All IRD fund holders →

FAQ

How long has Bleichroeder LP held IRD?

Bleichroeder LP has disclosed IRD holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Bleichroeder LP's current position in IRD?

As of Q2 2026, Bleichroeder LP holds 736.84K shares of IRD (OPUS GENETICS INC), valued at $3.03M, representing 0.54% of its reported portfolio and ranking #27.

Has Bleichroeder LP been buying or selling IRD?

In the latest 13F filing (Q2 2026), Bleichroeder LP held unchanged its position in IRD. The position peaked in Q1 2026 at 736.84K shares.

Which other funds hold IRD?

Other major institutional holders of IRD include Caligan Partners LP, BIOS Capital Management, LP, Boxer Capital Management, LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.